We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
How to show MHRA you're meeting good clinical practice (GCP) standards and what to expect from an inspection.
Information for health professionals on the epidemiology, transmission and prevention of Chlamydia abortus which can cause stillbirth or abortion in humans.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (6 March 2024) approved the Rubidium (Rb82) Generator (RUBY-FILL) as a diagnostic tool for imaging of the heart, to evaluate blood flow and aid in the diagnosis or assessment of...
Guidance for industry on flexible approaches to regulation we are taking during the COVID-19 outbreak.
Information about COVID-19 and pregnancy from the Royal College of Obstretricians and Gynaecologists (RCOG).
The MHRA has authorised cabotegravir as 30 mg tablets and as a 600 mg long-acting injection administered every two months
Find out about MCA's recruitment process for approved doctors (ADs).
Directory of current ICH Guidelines which have been implemented by the Medicines and Healthcare products Regulatory Agency.
International regulations and required documentation for hauliers transporting dangerous or hazardous goods by road or by vehicles on ships.
Crimean-Congo haemorrhagic fever (CCHF) is a viral haemorrhagic fever (VHF) caused by a virus of the Nairovirus group.
What you need to know before you can place a medical device on the Great Britain market with a UKCA mark.
Information on the programme, including commissioning, quality assurance, education and training.
Guidance and information about high consequence infectious diseases and their management in England.
This guidance covers ‘grandfathering’ and managing the lifecycle changes of medicinal products.
Use form C88 (status) as proof of authorisation to import or export for the country of destination.
This document explains the Down’s syndrome screening quality assurance support service (DQASS) and how to use it.
Information and guidance on a range of medical devices for users and patients.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).